Back to VA Vanguard Capital Management LLC
ERNA
1 quarters
Position history for VAVanguard Capital Management LLC's holdings in Ernexa Therapeutics Inc.
Yes. Vanguard Capital Management holds 5,684 shares of ERNA (Ernexa Therapeutics), worth $37,799, as of its Q2 2026 13F filing. It opened the position in Q2 2026.
Current Value
$37,799
Current Shares
5,684
Total Value Change
$0
Total Shares Change
0
Quarter-by-Quarter History
Other major holders of ERNA: Citadel Advisors LLC, Vanguard Fiduciary Trust Co., Geode Capital Management, LLC, Citigroup Inc., BlackRock, Inc.